The global oxidative stress assay market is anticipated to grow significantly at a CAGR of 7.5% over the forecast period (2021-2027). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. The companies are focusing on launches of new products to sustain in the competition. For instance, in May 2020, Arbor Assays introduced TBARS/MDA as an important addition to its extensive catalog of oxidative stress products. A new assay is a powerful tool for researchers studying the basic oxidative stress mechanisms linked to a variety of debilitating diseases.
A full report of Oxidative Stress Assay Market is available at: https://www.omrglobal.com/industry-reports/oxidative-stress-assay-market
Moreover, Thermo Fisher Scientific has a strong presence in emerging markets. It has a good online presence, and is driven by innovation that strengthened its position in the oxidative stress assays market. Further, Merck KGaA has a strong focus on R&D and has invested 14% or more of its revenue on R&D over the last three years. Merck also has a robust product portfolio, along with a strong geographic presence and brand name. These factors make Merck a dominant player in the global oxidative stress assays market. The company further strengthened its position in the oxidative stress assays market with the acquisition of Sigma-Aldrich in 2015.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/oxidative-stress-assay-market
The market is driven by the rising incidence of various cellular diseases. In particular, CVD and oncology are key application areas of use of devices for detecting oxidative stress markers. As per the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Over three-quarters of CVD deaths take place in low- and middle-income countries.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered- by product, by test type, and by technology.
- Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
- Competitive Landscape- Cell Biolabs, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Oxidative Stress Assay Market – Segmentation
By Product
- Consumables
- Instruments
By Test Type
- Nucleic Acid-Based Assays
- Lipid-Based Assays
- Protein-Based Assays
- Antioxidant Capacity Assays
- Enzyme-Based Assays
- Reactive Oxygen Species (ROS)-Based Assays
By Technology
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chromatography
- Flow Cytometry
- Microscopy
- High-Content Screening
This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.
